Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of DIGESTIEF CENTRUM is 0.2% (very low). The 2024 annual accounts show equity of €8k and a net result of €157k. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 10% of 383 sector peers (fiscal year 2024). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 4 annual accounts.
Signals
2 signals · with evidenceWeak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 10% of 383 sector peers (2024).
View the sector comparison Consistently profitable
Positive net result in the two most recent financial years (2023 and 2024).
View the result trend Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 17 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 12-08-2025, 12 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
How we compute the deadline
The year end is derived from 4 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 12-08-2025 | 12 d late | 2025-00376190 |
| 31-12-2023 | 31-07-2024 | 20-08-2024 | 20 d late | 2024-00353471 |
| 31-12-2022 | 31-07-2023 | 28-08-2023 | 28 d late | 2023-00410583 |
| 31-12-2021 | 31-07-2022 | 28-07-2022 | 3 d early | 2022-20250639 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsMore than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.2%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Young company
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€157k-18.3%
Working capital€-117k
Annual accounts & ratios
Source: NBB · 2024Annual accounts filed on 12-08-2025 with the NBB · fiscal year 2024 · verkort
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
stable
Equity: stable across 4 fiscal years (±0%/year).
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2024 · NACE 86, Human health · compared within the same schema type (abbreviated schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 0.3% | 50.4% | |
| Net result | €157k | €71k | |
| Equity | €8k | €128k | |
| Gross operating margin | €1.33M | €180k | |
| Staff costs | €923k | €135k |
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
P10
Stable position over 2021-2024
· n=158-383
P70
Stable position over 2021-2024
· n=157-373
P12
Stable position over 2021-2024
· n=158-383
P95
Stable position over 2021-2024
· n=152-373
Describes the position versus peers, not a forecast.
€403k
-5.3%
21-24
€157k
-18.3%
21-24
€353k
-3.9%
21-24
€2.66M
+6.3%
21-24
€8k
0.0%
21-24
€-117k
-
21-24
10
+4.0%
21-24
€923k
+14.1%
21-24
Show 12 other metrics
€29k
-14.5%
21-24
€157k
-18.3%
21-24
€2.64M
+6.1%
21-24
€2.32M
+23.9%
21-24
€291k
-50.8%
21-24
0.95
-9.9%
21-24
0.95
-9.9%
21-24
0.3%
-6.0%
21-24
330.00
+6.1%
21-24
1959.7%
-18.3%
21-24
5.9%
-23.1%
21-24
19.27
+9.4%
21-24
Figures by fiscal year
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €403k |
| Net profit | €157k |
| Cash flow | €353k |
| Staff costs | €923k |
| Income taxes | €29k |
| Dividends | €157k |
| Total assets | €2.66M |
| Equity | €8k |
| Debt | €2.64M |
| of which ≤ 1y | €2.32M |
| of which > 1y | €291k |
| Working capital | €-117k |
| Employees (FTE) | 10.3 |
Ratios (computed)
| 2024 | |
|---|---|
| Current ratio | 0.95 |
| Quick ratio | 0.95 |
| Working capital ratio | -4.4% |
| Solvency | 0.3% |
| Debt / equity | 330.00 |
| Long-term debt ratio | 36.32 |
| Interest coverage | 19.27 |
| Gross margin | - |
| Net margin | - |
| ROA | 5.9% |
| ROE | 1959.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Balance-sheet composition 2024
Full annual accounts (24 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €2.66M |
| Fixed assets | 21/28 | €453k |
| Intangible fixed assets | 21 | €153k |
| Tangible fixed assets | 22/27 | €301k |
| Current assets | 29/58 | €2.20M |
| Amounts receivable within one year | 40/41 | €2.10M |
| Cash & bank | 54/58 | €80k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €2.66M |
| Equity | 10/15 | €8k |
| Contributions / capital | 10/11 | €8k |
| Accumulated profits (losses) | 14 | €0 |
| Provisions & deferred taxes | 16 | €5k |
| Amounts payable | 17/49 | €2.64M |
| Amounts payable after one year | 17 | €291k |
| Amounts payable within one year | 42/48 | €2.32M |
| Trade debts payable within one year | 44 | €145k |
| Income statement | ||
| Gross operating margin | 9900 | €1.33M |
| Operating result | 9901 | €207k |
| Financial income | 75 | €11 |
| Financial charges | 65 | €21k |
| Result before taxes | 9903 | €186k |
| Income taxes | 67/77 | €29k |
| Net result for the period | 9904 | €157k |
| Result to be appropriated | 9905 | €157k |
This table shows the latest fiscal year. 3 prior years, with figures and ratios, belong to a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2024 · computed45
/ 100
Fair
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2024. Indicative, not credit advice.
Directors
Directors & mandates
11 directorsCurrent directors & mandates
-
Gastro-enteroloog Christophe Van SteenkisteLegal entityDirector· perm. rep.: Christophe VAN STEENKISTEState Gazette act 24157643 (05-11-2024)Current16-09-2024 → present
-
Dr Deceuninck MiekeLegal entityDirector· perm. rep.: Mieke DECEUNINCKState Gazette act 24060327 (12-04-2024)Current01-01-2024 → present
-
Dokter Els Monsaert Gastro-EnterologeLegal entityDirector· perm. rep.: Els MONSAERTState Gazette act 24060327 (12-04-2024)Current11-12-2023 → present
-
Dr. Nele Deprez – gastro-enterologieLegal entityDirector· perm. rep.: Nele DEPREZState Gazette act 23120011 (19-09-2023)Current01-08-2023 → present
-
Dr. Stefan Van Langendonck Gastro-EnterologieLegal entityDirector· perm. rep.: Stefan Van LangendonckState Gazette act 23040741 (23-03-2023)Current01-02-2023 → present
-
Dr. Thomas De Somer, Gastro-EnteroloogLegal entityDirector· perm. rep.: Thomas De SomerState Gazette act 22153150 (28-12-2022)Current01-10-2022 → present
Former directors (5)
-
Former- → 12-10-2025
-
Former- → 01-11-2024
-
DR. RASQUIN-DR. VAN LANGENHOVELegal entityDirector· perm. rep.: Koenraad RASQUINState Gazette act 24060259 (12-04-2024)Former- → 01-04-2024
-
Former- → 01-01-2024
-
DR. E. VANDERSTRAETENLegal entityDirector· perm. rep.: Erik VANDERSTRAETENState Gazette act 24060327 (12-04-2024)Former- → 10-12-2023
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Activiteiten van medisch specialisten(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 30-12-2020 |
| Status | Active |
| Postal code | 9000 |
Structure & network
Connections & network
7 connected companies1 further connections in this company's network. Available in Kantoor S.
See plans →Group structure
Sits on the board · 1 subsidiary · 1 location
Control→
Sits on the board · 1 subsidiary · 1 location
Control→
Sits on the board · 1 subsidiary · 1 location
Control→
Sits on the board · 1 subsidiary · 1 location
Control→
Show 2 more group companies
Sits on the board · 1 subsidiary · 2 locations
Control→
Sits on the board · 2 subsidiaries · 1 location
Control→
Network connections
Shared corporate director
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Ownership & control
6 partiesControl over this companysits on this company's board6
1 subsidiary · 2 locations
2 subsidiaries · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
1 subsidiary · 1 location
controls
DIGESTIEF CENTRUMBE 0760.667.070
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Locations & real estate
Registered office
from the Crossroads BankCannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Buitenring-Sint-Denijs 309000 GentEstablishment units
1 locationBuitenring-Sint-Denijs 30, 9000 Gent
since 20202.311.832.771
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area7.1 ha
Buildings1
Building footprint1.5 ha
Volume (LiDAR)287,088 m³
Tallest building44.2 m · ±6 fl.
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44809I0495/00N002 | Flanders | 7.1 ha | 1 · 1.5 ha | 44.2 m · 6 fl. |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
8 acts All acts · 8
updated 5 months ago
2026
19-02-2026 DOKTER ELS MONSAERT GASTRO ENTEROLOGE resigns as director
2024
05-11-2024 1 director appointed, 1 resigning
12-04-2024 Koenraad RASQUIN resigns as director
12-04-2024 2 directors appointed, 2 resigning
- Mieke DECEUNINCK, Bestuurder
- Els MONSAERT, Bestuurder
- Mieke DECEUNINCK, Bestuurder
- Erik VANDERSTRAETEN, Bestuurder
Summary:
v3.2
2023
19-09-2023 Nele DEPREZ appointed as director
23-03-2023 Stefan Van Langendonck appointed as director
2022
28-12-2022 Thomas De Somer appointed as director
2021
04-01-2021 Incorporation of a new SRL
Summary:
oprichting
Analysis
Financial profile
5 of 5 axes measured58
/ 100
Mixed profile: strong on profitability, weaker on solvency.
All 5 axes are computed from data Checked has read.
Health
45
Profitability
100
Solvency
10
Growth
42
Stability
94
Credit advice
verdict per customer and amountSimilar
Similar companies
Comparable size, same sectorBE 0752.778.594 · Sint-Lambrechts-Woluwe
BE 0776.655.046 · Herve
BE 0794.991.016 · Ukkel
BE 0755.856.464 · Vorst
BE 0751.974.781 · Liège
We hold annual accounts for 1,985 of the 16,606 companies in this sector. 623 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Praktijken van specialisten86220Activiteiten van medisch specialisten86220
Primary activity highlighted.
Names & trade names
| Legal nameNL | DIGESTIEF CENTRUM |
Registered office
Buitenring-Sint-Denijs 30
9000 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.